Improvement of digestive complaints in women with severe colorectal endometriosis benefiting from continuous amenorrhoea triggered by triptorelin. A prospective pilot study

H Roman, Horace Roman, M Saint Ghislain, Saint Ghislain M, Mathilde Saint Ghislain, Mathilde Milles, M Milles, Milles M, Marty N, N Marty, Hennetier C, Clotilde Hennetier, C Hennetier, S Moatassim, Moatassim S, E Desnyder, Desnyder E, Eulalie Desnyder, Abo C, Carole Abo, C Abo
Gynecologie, obstetrique & fertilite · 2015 · vol. 43(9) , pp. 575–581 · doi:10.1016/j.gyobfe.2015.07.001 · PMID:26234686 · W994326064
article OA: closed CC0 ⤵ 10 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This pilot study found that continuous amenorrhea induced by triptorelin improved digestive complaints in women with severe colorectal endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo assess the impact of therapeutic amenorrhoea triggered by triptorelin in the digestive complaints of women with deep endometriosis infiltrating the rectum.DesignProspective series of consecutive patients with deep endometriosis of the rectum enrolled over a period of 17 consecutive months.SettingUniversity tertiary referral center.PatientsSeventy patients.InterventionsMedical therapy (triptorelin 11.25 mg and add-back therapy using estradiol) administered for 3.4±1.8months before surgery.Main outcome measuresGastrointestinal standardised questionnaires before beginning medical treatment and the day before surgery.ResultsThe most frequent digestive complaints at baseline were: defecation pain in 77.1% of patients, bloating in 60%, diarrhoea in 54.3% and constipation in 50%. The largest diameter of the rectal area infiltrated by the disease was <1cm in 12.2% of women, 1 to 2.9 cm in 34.3% and ≥3cm in 51.4%. Multiple colorectal nodules were found in 32.9%. Medical treatment led to disappearance of cyclic defecation pain in 78.6%, dyschesia in 58.3%, diarrhoea in 58.3% and bloating in 50%. Relieving digestive complaints was not significantly related to either length of triptorelin administration or size of rectal infiltration by deep endometriosis.ConclusionTherapeutic amenorrhoea averaging 3 months allowed complete improvement of various cyclic digestive complaints in more than half of patients. In selected patients, continuous therapeutic amenorrhoea could compensate for the lack of complete resection of deep infiltrating endometriosis of the rectum, when this latter is likely to result in a high rate of postoperative morbidity.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Amenorrhea Colonic Diseases Digestive System Diseases Endometriosis Rectal Diseases Triptorelin Pamoate Amenorrhea Colonic Diseases Digestive System Diseases Digestive System Diseases Endometriosis Female Humans Luteolytic Agents Pain Prospective Studies Rectal Diseases Triptorelin Pamoate

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (10)

Source provenance

europepmc
last seen: 2026-07-30T06:25:42.655704+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:17:46.044120+00:00
License: CC0 · commercial use OK